Cutler Group LP Protagonist Therapeutics, Inc Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$7.06 - $25.52 $5,535 - $20,007	-784 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$23.34 - $36.08 $4,668 - $7,216	200 Added 34.25%	784 $18,000
Q4 2021 Jan 18, 2022	BUY	$17.63 - $37.1 $8,532 - $17,956	484 Added 484.0%	584 $19,000
Q3 2021 Oct 26, 2021	BUY	$12.95 - $49.69 $1,295 - $4,969	100 New	100 $1,000

247

56.4M

76.3K

114K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.